CXCL10 and melanoma: Together this data confirms that constitutive IκBζ expression in melanoma contributes to immunotherapy resistance, supposably by suppressing Ccl5, Cxcl9, and Cxcl10 expression, leading to a continuous exclusion of cytotoxic T cells and NK cells from the TME.